These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32060381)

  • 1. Effects of an SGLT2 inhibitor on the salt sensitivity of blood pressure and sympathetic nerve activity in a nondiabetic rat model of chronic kidney disease.
    Wan N; Fujisawa Y; Kobara H; Masaki T; Nakano D; Rahman A; Nishiyama A
    Hypertens Res; 2020 Jun; 43(6):492-499. PubMed ID: 32060381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na
    Kravtsova O; Bohovyk R; Levchenko V; Palygin O; Klemens CA; Rieg T; Staruschenko A
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F692-F707. PubMed ID: 35466690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burst patterning of hypothalamic paraventricular nucleus-driven sympathetic nerve activity in ANG II-salt hypertension.
    Holbein WW; Blackburn MB; Andrade MA; Toney GM
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H530-H541. PubMed ID: 29167122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease.
    Fujita M; Ando K; Kawarazaki H; Kawarasaki C; Muraoka K; Ohtsu H; Shimizu H; Fujita T
    Hypertension; 2012 Jan; 59(1):105-12. PubMed ID: 22083162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
    Carlson SH; Shelton J; White CR; Wyss JM
    Hypertension; 2000 Jan; 35(1 Pt 2):403-8. PubMed ID: 10642332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats.
    Rahman A; Fujisawa Y; Nakano D; Hitomi H; Nishiyama A
    Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):522-525. PubMed ID: 28063156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia.
    Yamazaki D; Konishi Y; Morikawa T; Kobara H; Masaki T; Hitomi H; Osafune K; Nakano D; Kittikulsuth W; Nishiyama A
    J Diabetes Investig; 2020 Jul; 11(4):834-843. PubMed ID: 31880858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II-dependent kidney damage.
    Reyes-Pardo H; Bautista R; Vargas-Robles H; Rios A; Sánchez D; Escalante B
    BMC Nephrol; 2019 Aug; 20(1):292. PubMed ID: 31375080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity.
    Wan N; Rahman A; Hitomi H; Nishiyama A
    Front Endocrinol (Lausanne); 2018; 9():421. PubMed ID: 30093883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats.
    Takeshige Y; Fujisawa Y; Rahman A; Kittikulsuth W; Nakano D; Mori H; Masaki T; Ohmori K; Kohno M; Ogata H; Nishiyama A
    Hypertens Res; 2016 Jun; 39(6):415-22. PubMed ID: 26818652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
    Reed JW
    Vasc Health Risk Manag; 2016; 12():393-405. PubMed ID: 27822054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity: a direct telemetric study.
    Guild SJ; McBryde FD; Malpas SC; Barrett CJ
    Hypertension; 2012 Mar; 59(3):614-20. PubMed ID: 22275533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary salt intake exaggerates sympathetic reflexes and increases blood pressure variability in normotensive rats.
    Simmonds SS; Lay J; Stocker SD
    Hypertension; 2014 Sep; 64(3):583-9. PubMed ID: 24914195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt-sensitivity of blood pressure and decreased 11beta-hydroxysteroid dehydrogenase type 2 activity after renal transplantation.
    Schumacher M; Frey FJ; Montani JP; Dick B; Frey BM; Ferrari P
    Transplantation; 2002 Jul; 74(1):66-72. PubMed ID: 12134101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity.
    Sano M
    J Cardiol; 2018 May; 71(5):471-476. PubMed ID: 29415819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.
    Kawasoe S; Maruguchi Y; Kajiya S; Uenomachi H; Miyata M; Kawasoe M; Kubozono T; Ohishi M
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):23. PubMed ID: 28391776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.
    Rahman A; Hitomi H; Nishiyama A
    Hypertens Res; 2017 Jun; 40(6):535-540. PubMed ID: 28100918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic control of BP and BP variability in borderline hypertensive rats on high- vs. low-salt diet.
    Brown DR; Li SG; Lawler JE; Randall DC
    Am J Physiol; 1999 Sep; 277(3):R650-7. PubMed ID: 10484480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-salt diet does not influence renal sympathetic nerve activity: a direct telemetric investigation.
    McBryde FD; Malpas SC; Guild SJ; Barrett CJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Aug; 297(2):R396-402. PubMed ID: 19494174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.
    Sufiun A; Rafiq K; Fujisawa Y; Rahman A; Mori H; Nakano D; Kobori H; Ohmori K; Masaki T; Kohno M; Nishiyama A
    Hypertens Res; 2015 Apr; 38(4):237-43. PubMed ID: 25588850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.